2NO0

c4s dck variant of dck in complex with gemcitabine+adp

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: A-B
  • Int. Res.: 129
  • Norm. En. per Res.: -3.9935
• Hub Node: A(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	-37.0162	-105.7406	-372.402	-515.1588	129	14	6	15007	15	26	16

Interface residues

• A-B: ALA100A, ALA100B, ALA107A, ALA107B, ALA110A, ALA110B, ARG106A, ARG106B, ARG134A, ARG134B, ARG57A, ARG57B, ARG91A, ARG91B, ASN113A, ASN148A, ASN148B, ASN163B, ASN164A, ASN164B, ASN224A, ASN224B, ASN60A, ASN60B, ASN77A, ASN80A, ASN80B, ASP157A, ASP157B, ASP160A, ASP160B, ASP226B, ASP66A, CYS101A, CYS101B, GLN108A, GLN108B, GLN156A, GLN156B, GLN165A, GLN165B, GLN62A, GLN62B, GLN65A, GLN75A, GLN97A, GLN97B, GLU149A, GLU149B, GLU151A, GLU151B, GLU67A, GLU90A, GLU90B, GLY78A, GLY78B, GLY79A, GLY79B, HIS159A, HIS159B, ILE105A, ILE105B, ILE154A, ILE154B, LEU102A, LEU102B, LEU109A, LEU109B, LEU170A, LEU170B, LEU82A, LEU82B, LYS222B, LYS76A, LYS88A, LYS88B, MET147A, MET147B, MET162A, MET162B, MET84A, MET84B, MET85A, PHE166A, PHE166B, PHE68A, PHE94A, PHE94B, PHE96A, PHE96B, PRO89A, PRO89B, SER103A, SER103B, SER146A, SER146B, SER63A, SER63B, SER93A, SER93B, THR150A, THR150B, THR153A, THR153B, THR223B, THR64A, THR64B, THR95A, THR95B, THR98A, THR98B, TRP152A, TRP152B, TRP158A, TRP158B, TRP161A, TRP161B, TRP58A, TRP58B, TRP92A, TRP92B, TYR155A, TYR155B, TYR99A, TYR99B, VAL61A, VAL61B, VAL81A, VAL81B